Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Turmeric and Reduced C-Reactive Protein Levels

Research synthesisModerate evidenceModerate effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Turmeric (curcumin) shows moderate evidence for reducing C-reactive protein levels, with 3 of 4 studies reporting beneficial effects of moderate magnitude. The median study duration was 42 days, and effects were observed primarily in clinical populations (rheumatoid arthritis, type 2 diabetes, metabolic syndrome).

  • Studied populations: adults with chronic inflammatory conditions (rheumatoid arthritis, type 2 diabetes, metabolic syndrome)

Caveats: The evidence base is small (4 studies); one meta-analysis with a large effect size had very low quality evidence. A single study in athletes showed no significant effect, suggesting that benefits may be limited to populations with existing inflammation.

Generated May 17, 2026
Doses used in studies
  • g/day: 2 (median 2, IQR 22) 1 study
Time to effect
Median: 6 weeks · IQR 6 weeks6 weeks · Range 6 weeks6 weeks — Reported in 1 of 4 studies
Safety in these studies
4 of 4 papers
Back to top